DLK2 and nonpapillary renal cell carcinoma: At the same time, we also found that DLK2 may serve as a potent oncogene in ccRCC by regulating ECM remodeling, mitochondria metabolism, ribosome biogenesis, TGF-β signaling, and Notch pathway.